BAR HARBOR, MAINE — The MDI Biological Laboratory and the University of New England (UNE) are bringing Maine researchers together to discuss how they can collaborate to identify solutions to the opioid epidemic in Maine.
In a first step toward this goal, the institution will hold a panel discussion on the opioid crisis at the upcoming 46th Maine Biological and Medical Sciences Symposium (MBMSS), an annual statewide gathering at which students and scientists have the opportunity to network, collaborate, exchange ideas and share research results.
As a professor of pharmacology, Houseknecht leads a National Institutes of Health (NIH)-funded research program that studies the pharmacology of psychiatric medications and emerging drugs of abuse.
An audience discussion on the scientific resources that are being devoted to the opioid crisis will follow the panel discussion.
The rate of opioid-related overdose deaths in Maine is nearly double the national rate and the state ranks among the top 10 in the rate of opioid-related overdose deaths, according to the National Institute on Drug Abuse.
Maine is one of many states with federal IDeA (Institutional Development Award) funding that are prioritizing research focused on reducing the burden of opioid addiction, according to the National Institute of General Medical Sciences, which administers the IDeA program.